POSTTRANSCRIPTIONAL REGULATION--CATECHOLAMINE SYNTHESIS
转录后调控——儿茶酚胺合成
基本信息
- 批准号:2685536
- 负责人:
- 金额:$ 22.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-04-01 至 2001-03-31
- 项目状态:已结题
- 来源:
- 关键词:RNA binding protein biosynthesis catecholamines complementary DNA endoribonucleases enzyme activity enzyme induction /repression hypoxia laboratory rat messenger RNA molecular cloning posttranscriptional RNA processing protein sequence site directed mutagenesis tissue /cell culture tyrosine 3 monooxygenase
项目摘要
Catecholamines (CA) are essential neurotransmitters expressed and regulated
in the neuronal pathway involved in respirator and cardiovascular
adaptation to acute and chronic hypoxia. Regulation of CA synthesis during
hypoxia occurs often at the level of the rate limiting enzyme in CA
synthesis, tyrosine hydroxylase (THE). The dopaminergic PC12 cell line is
frequently used for molecular studies of THE regulation. In PC12 cells,
hypoxia increases concentration of THE protein (and thus dopamine
synthesis) resulting from transcriptional induction of THE gene and an
increase in the THE mRNA half-life from 10 to 30 h. The objective of the
present proposal is to study molecular mechanisms involved in regulation
of THE mRNA stability. This regulation is important because leads to long-
term changes in THE mRNA, and therefore THE protein, and is energetically
effective and economic for maintaining elevated levels of THE mRNA during
energetic deprivation such as chronic hypoxia.
The increased stability of the THE mRNA during hypoxia is accompanied by
enhanced binding of a hypoxia-inducible protein (HIP) to a 27 base long
cytidine-rich sequence (1551-1579) in the 3 untranslated region of the THE
mRNA (hypoxia-inducible protein binding sequence, HIPBS). The hypothesis
for the proposed research is that HIPBS and its binding protein are
regulators of the THE mRNA constitutive and O2-regulated half-life. It is
hypothesized that HIPBS is associated with the site for endoribonuclease
activity and protein binding protects THE mRNA from cleavage. Thus
increased binding of protein to HIPBS during hypoxia results in augmented
mRNA stability. We shall determine whether HIPBS is necessary and
sufficient for regulation of both constitutive and O2-regulated half-life
of the THE mRNA and whether this regulation is specific for
catecholaminergic or O2-sensitive cells. The cell-free in vitro RNA decay
assays will be developed to determine whether HIPBS is a site for nuclease
cleavage and whether binding of protein to HIPBS protects mRNA from
degradation. The HIPBS binding protein will be purified using poly(C) RNA
affinity, cloned, and its expression and potential regulation by O2 will
be studied in different catecholaminergic tissues. Finally, a PC12 cell
line will be developed stably expressing THE mRNA under control of a
chimeric tetracycline-regulated and THE tissue-specific promoter. Such
system is necessary to study THE mRNA stability regulation without non-
specific transcription blockers and will facilitate future studies of mRNA
stability in the transgenic animals.
儿茶酚胺 (CA) 是表达和调节的重要神经递质
参与呼吸和心血管的神经元通路
适应急、慢性缺氧。 CA合成过程中的调节
缺氧通常发生在 CA 限速酶水平
合成,酪氨酸羟化酶(THE)。多巴胺能 PC12 细胞系是
经常用于THE调节的分子研究。在 PC12 细胞中,
缺氧会增加蛋白质的浓度(因此多巴胺
合成)由THE基因的转录诱导产生,并且
THE mRNA 半衰期从 10 小时增加至 30 小时。该计划的目标
目前的建议是研究参与调节的分子机制
mRNA 稳定性。这项规定很重要,因为会导致长期
mRNA 的术语发生变化,因此蛋白质也发生变化,并且在能量上
有效且经济地维持THE mRNA的升高水平
能量匮乏,例如慢性缺氧。
缺氧期间THE mRNA稳定性的增加伴随着
增强缺氧诱导蛋白 (HIP) 与 27 个碱基长的结合
THE 的 3 个非翻译区富含胞苷序列 (1551-1579)
mRNA(缺氧诱导蛋白结合序列,HIPBS)。假设
对于拟议的研究,HIPBS 及其结合蛋白是
THE mRNA 组成型和 O2 调节半衰期的调节因子。这是
假设 HIPBS 与核糖核酸内切酶位点相关
活性和蛋白质结合可保护 mRNA 免遭切割。因此
缺氧期间蛋白质与 HIPBS 的结合增加,导致增强
mRNA 稳定性。我们将确定 HIPBS 是否必要,以及
足以调节本构半衰期和 O2 调节半衰期
THE mRNA 的变化以及该调节是否特异于
儿茶酚胺能或 O2 敏感细胞。体外游离RNA衰变
将开发测定法以确定 HIPBS 是否是核酸酶位点
裂解以及蛋白质与 HIPBS 的结合是否可以保护 mRNA
降解。 HIPBS 结合蛋白将使用聚 (C) RNA 进行纯化
亲和力、克隆及其表达和 O2 的潜在调节将
在不同的儿茶酚胺能组织中进行研究。最后是PC12电池
将在a的控制下开发稳定表达mRNA的细胞系
嵌合四环素调节的组织特异性启动子。这样的
系统对于研究 mRNA 稳定性调节而无需非
特异性转录阻断剂,将促进未来 mRNA 的研究
转基因动物的稳定性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Maria F Czyzyk-Krzeska其他文献
Maria F Czyzyk-Krzeska的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Maria F Czyzyk-Krzeska', 18)}}的其他基金
相似海外基金
BIOSYNTHESIS AND RELEASE OF OPIOID PEPTIDES AND CATECHOLAMINES IN THE HAMSTER
仓鼠中阿片肽和儿茶酚胺的生物合成和释放
- 批准号:
3752952 - 财政年份:
- 资助金额:
$ 22.37万 - 项目类别:
BIOSYNTHESIS AND RELEASE OF OPIOID PEPTIDES AND CATECHOLAMINES
阿片肽和儿茶酚胺的生物合成和释放
- 批准号:
3874876 - 财政年份:
- 资助金额:
$ 22.37万 - 项目类别:
BIOSYNTHESIS AND RELEASE OF OPIOID PEPTIDES AND CATECHOLAMINES
阿片肽和儿茶酚胺的生物合成和释放
- 批准号:
3896453 - 财政年份:
- 资助金额:
$ 22.37万 - 项目类别:
BIOSYNTHESIS AND RELEASE OF OPIOID PEPTIDES AND CATECHOLAMINES IN THE HAMSTER
仓鼠中阿片肽和儿茶酚胺的生物合成和释放
- 批准号:
3775101 - 财政年份:
- 资助金额:
$ 22.37万 - 项目类别:
BIOSYNTHESIS AND RELEASE OF OPIOID PEPTIDES AND CATECHOLAMINES IN THE HAMSTER
仓鼠中阿片肽和儿茶酚胺的生物合成和释放
- 批准号:
5209628 - 财政年份:
- 资助金额:
$ 22.37万 - 项目类别:
BIOSYNTHESIS AND RELEASE OF OPIOID PEPTIDES AND CATECHOLAMINES IN THE HAMSTER
仓鼠中阿片肽和儿茶酚胺的生物合成和释放
- 批准号:
2663387 - 财政年份:
- 资助金额:
$ 22.37万 - 项目类别:














{{item.name}}会员




